These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 17395699)

  • 1. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy.
    Kuzman JA; O'Connell TD; Gerdes AM
    Endocrinology; 2007 Jul; 148(7):3477-84. PubMed ID: 17395699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of cardiac hypertrophy by inhibiting both mTOR and NFkappaB activation in vivo.
    Ha T; Li Y; Gao X; McMullen JR; Shioi T; Izumo S; Kelley JL; Zhao A; Haddad GE; Williams DL; Browder IW; Kao RL; Li C
    Free Radic Biol Med; 2005 Dec; 39(12):1570-80. PubMed ID: 16298682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
    Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O
    J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin attenuates load-induced cardiac hypertrophy in mice.
    Shioi T; McMullen JR; Tarnavski O; Converso K; Sherwood MC; Manning WJ; Izumo S
    Circulation; 2003 Apr; 107(12):1664-70. PubMed ID: 12668503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid hormone improves the mechanical performance of the post-infarcted diabetic myocardium: a response associated with up-regulation of Akt/mTOR and AMPK activation.
    Mourouzis I; Giagourta I; Galanopoulos G; Mantzouratou P; Kostakou E; Kokkinos AD; Tentolouris N; Pantos C
    Metabolism; 2013 Oct; 62(10):1387-93. PubMed ID: 23773982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shp2 negatively regulates growth in cardiomyocytes by controlling focal adhesion kinase/Src and mTOR pathways.
    Marin TM; Clemente CF; Santos AM; Picardi PK; Pascoal VD; Lopes-Cendes I; Saad MJ; Franchini KG
    Circ Res; 2008 Oct; 103(8):813-24. PubMed ID: 18757826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway.
    Diniz GP; Carneiro-Ramos MS; Barreto-Chaves ML
    Basic Res Cardiol; 2009 Nov; 104(6):653-67. PubMed ID: 19588183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts.
    Cao X; Kambe F; Moeller LC; Refetoff S; Seo H
    Mol Endocrinol; 2005 Jan; 19(1):102-12. PubMed ID: 15388791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 17ß-Estradiol regulates mTORC2 sensitivity to rapamycin in adaptive cardiac remodeling.
    Kusch A; Schmidt M; Gürgen D; Postpieszala D; Catar R; Hegner B; Davidson MM; Mahmoodzadeh S; Dragun D
    PLoS One; 2015; 10(4):e0123385. PubMed ID: 25880554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways.
    Clemente CF; Xavier-Neto J; Dalla Costa AP; Consonni SR; Antunes JE; Rocco SA; Pereira MB; Judice CC; Strauss B; Joazeiro PP; Matos-Souza JR; Franchini KG
    J Mol Cell Cardiol; 2012 Feb; 52(2):493-501. PubMed ID: 22056317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKD deletion promotes autophagy and inhibits hypertrophy in cardiomyocyte.
    Zhao D; Gao Y; Wang W; Pei H; Xu C; Zhao Z
    Exp Cell Res; 2020 Jan; 386(2):111742. PubMed ID: 31759056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways.
    Kenessey A; Ojamaa K
    J Biol Chem; 2006 Jul; 281(30):20666-20672. PubMed ID: 16717100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bidirectional regulation of nuclear factor-κB and mammalian target of rapamycin signaling functionally links Bnip3 gene repression and cell survival of ventricular myocytes.
    Dhingra R; Gang H; Wang Y; Biala AK; Aviv Y; Margulets V; Tee A; Kirshenbaum LA
    Circ Heart Fail; 2013 Mar; 6(2):335-43. PubMed ID: 23395931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone induces cardiomyocyte hypertrophy through mammalian target of rapamycin complex 1 pathway.
    Altamirano F; Oyarce C; Silva P; Toyos M; Wilson C; Lavandero S; Uhlén P; Estrada M
    J Endocrinol; 2009 Aug; 202(2):299-307. PubMed ID: 19474060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload.
    McMullen JR; Sherwood MC; Tarnavski O; Zhang L; Dorfman AL; Shioi T; Izumo S
    Circulation; 2004 Jun; 109(24):3050-5. PubMed ID: 15184287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling.
    Ai W; Zhang Y; Tang QZ; Yan L; Bian ZY; Liu C; Huang H; Bai X; Yin L; Li H
    J Cell Biochem; 2010 Aug; 110(5):1111-22. PubMed ID: 20564207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-Thyroxine activates Akt signaling in the heart.
    Kuzman JA; Vogelsang KA; Thomas TA; Gerdes AM
    J Mol Cell Cardiol; 2005 Aug; 39(2):251-8. PubMed ID: 15890358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKD knockdown inhibits pressure overload-induced cardiac hypertrophy by promoting autophagy via AKT/mTOR pathway.
    Zhao D; Wang W; Wang H; Peng H; Liu X; Guo W; Su G; Zhao Z
    Int J Biol Sci; 2017; 13(3):276-285. PubMed ID: 28367092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLK11 promotes the activation of mTOR and protein synthesis to facilitate cardiac hypertrophy.
    Wang Y; Liao H; Wang Y; Zhou J; Wang F; Xie Y; Zhao K; Gao W
    BMC Cardiovasc Disord; 2021 May; 21(1):266. PubMed ID: 34059001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.